These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 1394215)

  • 1. A comparison of the abilities of nitrobenzylthioinosine, dilazep, and dipyridamole to protect human hematopoietic cells from 7-deazaadenosine (tubercidin).
    Cass CE; King KM; Montaño JT; Janowska-Wieczorek A
    Cancer Res; 1992 Nov; 52(21):5879-86. PubMed ID: 1394215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transport and metabolism of 9-beta-D-arabinofuranosylguanine in a human T-lymphoblastoid cell line: nitrobenzylthioinosine-sensitive and -insensitive influx.
    Prus KL; Averett DR; Zimmerman TP
    Cancer Res; 1990 Mar; 50(6):1817-21. PubMed ID: 2306735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycine 154 of the equilibrative nucleoside transporter, hENT1, is important for nucleoside transport and for conferring sensitivity to the inhibitors nitrobenzylthioinosine, dipyridamole, and dilazep.
    SenGupta DJ; Unadkat JD
    Biochem Pharmacol; 2004 Feb; 67(3):453-8. PubMed ID: 15037197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in nucleoside transport of HL-60 human promyelocytic cells during N,N-dimethylformamide induced differentiation.
    Chen SF; Cleaveland JS; Hollmann AB; Wiemann MC; Parks RE; Stoeckler JD
    Cancer Res; 1986 Jul; 46(7):3449-55. PubMed ID: 3486711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of nucleoside and nucleobase transport and nitrobenzylthioinosine binding by dilazep and hexobendine.
    Plagemann PG; Kraupp M
    Biochem Pharmacol; 1986 Aug; 35(15):2559-67. PubMed ID: 3741459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The suppressive influences of human tumor necrosis factors on bone marrow hematopoietic progenitor cells from normal donors and patients with leukemia: synergism of tumor necrosis factor and interferon-gamma.
    Broxmeyer HE; Williams DE; Lu L; Cooper S; Anderson SL; Beyer GS; Hoffman R; Rubin BY
    J Immunol; 1986 Jun; 136(12):4487-95. PubMed ID: 3086433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of recombinant human tumor necrosis factor on highly enriched hematopoietic progenitor cell populations from normal human bone marrow and peripheral blood and bone marrow from patients with chronic myeloid leukemia.
    Wisniewski D; Strife A; Atzpodien J; Clarkson BD
    Cancer Res; 1987 Sep; 47(18):4788-94. PubMed ID: 3040231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nitrobenzylthioinosine-sensitive nucleoside transport system: mechanism of inhibition by dipyridamole.
    Jarvis SM
    Mol Pharmacol; 1986 Dec; 30(6):659-65. PubMed ID: 3785142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimalarial action of nitrobenzylthioinosine in combination with purine nucleoside antimetabolites.
    Gero AM; Scott HV; O'Sullivan WJ; Christopherson RI
    Mol Biochem Parasitol; 1989 Apr; 34(1):87-97. PubMed ID: 2651920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of adenosine uptake and metabolism by blood cells in the antiplatelet actions of dipyridamole, dilazep and nitrobenzylthioinosine.
    Dawicki DD; Agarwal KC; Parks RE
    Biochem Pharmacol; 1985 Nov; 34(22):3965-72. PubMed ID: 4062970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of [3H]dilazep at nucleoside transporter-associated binding sites on S49 mouse lymphoma cells.
    Gati WP; Paterson AR
    Mol Pharmacol; 1989 Jul; 36(1):134-41. PubMed ID: 2747624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sodium-dependent and equilibrative nucleoside transport systems in L1210 mouse leukemia cells: effect of inhibitors of equilibrative systems on the content and retention of nucleosides.
    Dagnino L; Paterson AR
    Cancer Res; 1990 Oct; 50(20):6549-53. PubMed ID: 1698538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytotoxic activity of an anti-transferrin receptor immunotoxin on normal and leukemic human hematopoietic progenitors.
    Cazzola M; Bergamaschi G; Dezza L; D'Uva R; Ponchio L; Rosti V; Ascari E
    Cancer Res; 1991 Jan; 51(2):536-41. PubMed ID: 1985771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological analysis and molecular cloning of the canine equilibrative nucleoside transporter 1.
    Hammond JR; Stolk M; Archer RG; McConnell K
    Eur J Pharmacol; 2004 Apr; 491(1):9-19. PubMed ID: 15102528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor necrosis factor-alpha and hematopoietic progenitors: effects of tumor necrosis factor on the growth of erythroid progenitors CFU-E and BFU-E and the hematopoietic cell lines K562, HL60, and HEL cells.
    Roodman GD; Bird A; Hutzler D; Montgomery W
    Exp Hematol; 1987 Oct; 15(9):928-35. PubMed ID: 2820776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of inhibitor-sensitive and -resistant adenosine transporters in cultured human fetal astrocytes.
    Gu JG; Nath A; Geiger JD
    J Neurochem; 1996 Sep; 67(3):972-7. PubMed ID: 8752102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro cytotoxicity of VP-16-213 and nitrogen mustard: agonistic on tumor cells but not on normal human bone marrow progenitors.
    Lemoli RM; Gulati SC
    Exp Hematol; 1990 Oct; 18(9):1008-12. PubMed ID: 2397748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of tubercidin host toxicity by nitrobenzylthioinosine 5'-monophosphate for the treatment of schistosomiasis.
    el Kouni MH; Diop D; O'Shea P; Carlisle R; Sommadossi JP
    Antimicrob Agents Chemother; 1989 Jun; 33(6):824-7. PubMed ID: 2764531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transport and metabolism of adenosine in human erythrocytes: effect of transport inhibitors and regulation by phosphate.
    Plagemann PG
    J Cell Physiol; 1986 Sep; 128(3):491-500. PubMed ID: 3488996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of schistosomiasis by purine nucleoside analogues in combination with nucleoside transport inhibitors.
    el Kouni MH; Messier NJ; Cha S
    Biochem Pharmacol; 1987 Nov; 36(22):3815-21. PubMed ID: 3689423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.